Skip to Content
Merck
CN
  • Transdermal delivery of butamben using elastic and conventional liposomes.

Transdermal delivery of butamben using elastic and conventional liposomes.

Journal of liposome research (2013-05-24)
Cintia Maria Saia Cereda, Michelle Franz-Montan, Camila Morais Gonçalves da Silva, Bruna Renata Casadei, Cleyton Crepaldi Domingues, Giovana Radomille Tofoli, Daniele Ribeiro de Araujo, Eneida de Paula
ABSTRACT

Gel formulations containing the local anesthetic butamben (BTB) encapsulated in either conventional (BTBLUV) or elastic (BTBLUV-EL) liposomes were prepared and characterized, and then evaluated in terms of their skin permeability. Parameters measured included vesicle size and surface charge, BTB fluorescence anisotropy, encapsulation efficiency, partition coefficient and liposomal membrane organization. Encapsulation efficiencies and membrane/water partition coefficients were determined using a phase separation. The partition coefficients of the elastic and conventional formulations were 2025 ± 234 and 1136 ± 241, respectively. The sizes of the elastic and conventional liposomes did not change significantly (p > 0.05) following incorporation of the anesthetic. As expected, the elastic liposomes presented order parameters that were lower than those of the conventional liposomes, as determined by electron paramagnetic resonance with a 5-stearic acid nitroxide probe incorporated into the bilayer. After 8 h, the fluxes into the receiving solution (µg/cm(2)/h) were 6.95 ± 1.60 (10% BTB), 23.17 ± 6.09 (10% BTBLUV) and 29.93 ± 6.54 (10% BTBLUV-EL). The corresponding time lags (h) were 1.90 ± 0.48, 1.23 ± 0.28 and 1.57 ± 0.38, respectively. The permeability coefficients (10(-3 )cm/h) were 1.02 ± 0.23, 2.96 ± 0.77 and 4.14 ± 0.9, for 10% BTB, 10% BTBLUV and 10% BTBLUV-EL, respectively. The results demonstrate that anesthetic access through the skin can be considerably enhanced using liposomal gel formulations, compared to plain gel formulations.

MATERIALS
Product Number
Brand
Product Description

Supelco
Benzocaine, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Benzocaine, ≥99% (HPLC)
Sigma-Aldrich
Ethyl 4-aminobenzoate, 98%